Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates
- 2 July 2024
- journal article
- research article
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 71 (2) , 134-139
Abstract
The rate of pandrug-resistant Acinetobacter baumannii strains is on the rise in all continents. This bacterium can acquire resistance to all antibiotics, even to colistin. Alterations in the lipid A or/and the two-component pmrAB were earlier detected in colistin resistance. We investigated and analyzed two strains of A. baumannii (ABRC1 and ABRC2) isolated from two patients admitted to intensive care unit with a septic shock. Both strains were resistant to all tested antibiotics including colistin with a MIC >256 mg L−1. Colistin resistance genes (pmrA, pmrB, lpxA, lpxC, lpxD, and lpsB) of two strains (ABRC1 and ABRC2) were investigated by PCR and sequencing. Obtained nucleic acid sequences were aligned with reference sequences of ATCC 19606 and 17987. In this study two amino acid mutations, N287D in the lpxC gene and E117K in the lpxD gene, were detected in both ABRC1 and ABRC2 strains. ABRC1 had an additional H200L mutation in the pmrA gene. Both colistin resistant strains harbored the same A138T mutation in the pmrB gene. The ABRC2 strain also had an alteration in the kinase domain, specifically an R263S substitution of the histidine kinase domain. Three identical mutations were found in the lpsB gene of both A. baumannii strains: Q216K + H218G + S219E. As a result, a newly deduced protein sequence in both ABRC1 and ABRC2 strains differed from those described in ATCC 17978 and 19606 strains was determined. Colistin resistance is multifactorial in A. baumannii. In our study we detected novel mutations in colistin resistant A. baumannii clinical isolates.Keywords
This publication has 24 references indexed in Scilit:
- Structure and dynamics of polymyxin-resistance-associated response regulator PmrA in complex with promoter DNANature Communications, 2015
- Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatmentGenome Research, 2013
- In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumanniiClinical Microbiology and Infection, 2012
- The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid AAntimicrobial Agents and Chemotherapy, 2011
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory SystemAntimicrobial Agents and Chemotherapy, 2011
- Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumanniiInternational Journal of Antimicrobial Agents, 2011
- Two-component signal transduction as potential drug targets in pathogenic bacteriaCurrent Opinion in Microbiology, 2010
- Atomic Force Microscopy Investigation of the Morphology and Topography of Colistin-Heteroresistant Acinetobacter baumannii Strains as a Function of Growth Phase and in Response to Colistin TreatmentAntimicrobial Agents and Chemotherapy, 2009
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control studyCritical Care Medicine, 2008
- Clinical impact and pathogenicity of AcinetobacterClinical Microbiology and Infection, 2005